SFG
IBB icon

Strive Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Strive Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
587
-47
-7% -$8.08K 0.05% 196
2026
Q1 		$107K Sell
634
-45
-7% -$7.7K 0.06% 157
2025
Q4 		$115K Buy
+679
New +$110K 0.06% 153

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Strive Financial Group's IBB Position: Q2 2026 in Review

Strive Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 7.4% in Q2 2026, selling an estimated $8.08K and leaving 587 shares worth $112K. The position accounts for 0.05% of the portfolio, ranked #196.

Strive Financial Group first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. The position peaked at $115K in Q4 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Strive Financial Group held 587 shares of iShares Biotechnology ETF worth $112K as of Q2 2026.
  • Strive Financial Group sold 47 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.08K.
  • iShares Biotechnology ETF made up 0.05% of Strive Financial Group's portfolio in Q2 2026, its #196 holding.
  • Strive Financial Group first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's iShares Biotechnology ETF position peaked at $115K in Q4 2025.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.